Results

Total Results: 621 records

Showing results for "hypertension".
Users also searched for: diabetes

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
    February 01, 2010 - variables consisting of demographics (age, sex, and ethnicity), cardiac risk factors (diabetes, smoking, hypertension … The interaction of diabetes with treatment remained after adjustment for age, sex, smoking, hypertension … interaction between age and treatment effect remained after adjustment for sex, diabetes, smoking, hypertension
  2. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - contributor to many diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease, hypertension … or greater (overweight) in the presence of at least one weight related comorbid condition (e.g., hypertension … or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension … ≥30 kg/m 2 or a BMI ≥ 25 kg/m 2 with comorbid obesity-related risk factors or diseases (e.g., hypertension
  3. effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
    December 01, 2009 - were peptic ulcer disease (PUD), gastroesophogeal reflux disease (GERD), arrhythmias, depression, hypertension … corticosteroids; IPRA = ipratropium; THEO = theophylline Propensity model included age, race, VISN, incident, hypertension … corticosteroids; IPRA = ipratropium; THEO = theophylline Propensity model included age, race, VISN, incident, hypertension … = ipratropium; THEO = theophylline Propensity model adjusted for age, rage, VISN, incident COPD, hypertension
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
    December 01, 2009 - were peptic ulcer disease (PUD), gastroesophogeal reflux disease (GERD), arrhythmias, depression, hypertension … corticosteroids; IPRA = ipratropium; THEO = theophylline Propensity model included age, race, VISN, incident, hypertension … corticosteroids; IPRA = ipratropium; THEO = theophylline Propensity model included age, race, VISN, incident, hypertension … = ipratropium; THEO = theophylline Propensity model adjusted for age, rage, VISN, incident COPD, hypertension
  5. effectivehealthcare.ahrq.gov/products/off-label-use-research-priorities/research
    June 29, 2009 - Schizophrenia   9 celecoxib Joint Sprain/ Strain Fibromatosis Enthesopathy   10 lisinopril Hypertension
  6. effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
    March 29, 2012 - For example, consider two drugs used to treat hypertension—calcium channel blockers (CCB) and diuretics … Since many clinicians perceive CCBs as particularly useful in treating high-risk patients with hypertension … that physicians were more likely to prescribe CCBs to high-risk patients than for uncomplicated hypertension
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
    December 05, 2018 - APGAR, withdrawal, respiratory distress, neonatal intensive care unit time, persistent pulmonary hypertension … Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. … Labor, Premature"[Mesh] OR "Persistent Fetal Circulation Syndrome"[Mesh] OR "Persistent Pulmonary Hypertension
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
    July 01, 2014 - Other specific adverse events, such as withdrawal symptoms (neonatal abstinence symptoms), pulmonary hypertension … birth, small for gestational age, neonatal mortality, congenital malformations, persistent pulmonary hypertension … We found no direct evidence on the risk of neonatal withdrawal symptoms or pulmonary hypertension with … Indirect evidence suggested that persistent pulmonary hypertension in the child was statistically significantly … Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
    March 08, 2012 - Systemic adverse effects of decongestants may include hypertension, irritability, tachycardia, dizziness … 2012 4 caution, if at all, in patients with diabetes mellitus, ischemic heart disease, unstable hypertension … contraindicated with coadministered monoamine oxidase inhibitors and in patients with uncontrolled hypertension … pregnancy, in children, and in those whose treatment choices are restricted due to comorbidities, such as hypertension … www.effectivehealthcare.ahrq.gov Published Online: March 8, 2012 13 • Sympathomimetic decongestants o Systemic effects: hypertension
  10. effectivehealthcare.ahrq.gov/sites/default/files/cer-237-integrating-palliative-care-disposition-comments.pdf
    February 11, 2021 - that a review of the role of cardiology specialists in the care of a very common heart problem like hypertension … would assume that a great deal of hypertension care is being done by others.
  11. effectivehealthcare.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research
    March 18, 2009 - 1.4 1.4 Cerebrovascular disease 29.1 30.9 CHF 32.6 31.1 Diabetes 25.8 26.8 Hypertension … for calendar year, age, gender, race, prior arrhythmias, cerebrovascular disease, CHF, diabetes, MI, hypertension
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/people-with-disabilities-draft-report-app-e-f.xlsx
    January 01, 2022 - : NR Economic status: NR Geographic location: NR NR Moderate Chauhan 2010 Cross-sectional 634 UK Hypertension … Economic status: NR Geographic location: NR Government Low Lennox 2007 Cluster RCT 453 Australia Hypertension … . 32% (16/50); adjusted OR 1.0 (95% CI 0.5 to 2.2) NR NR Durbin 2019 and Durbin 2016 Cognitive/IDD Hypertension … 6/55); adjusted OR 0.2 (95% CI 0.0 to 1.0) NR NR Lennox 2010                         Cognitive/IDD Hypertension … Narrative report of no adverse effects from CHAP Lennox 2010                         Cognitive/IDD Hypertension
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fetal-treatment-key-questions.pdf
    January 01, 2023 - preterm birth, oligohydramnios, constriction of the fetal ductus arteriosus; maternal harms such as hypertension
  14. effectivehealthcare.ahrq.gov/products/depression-chronic-conditions-interventions/research-protocol
    September 21, 2011 - diabetes, asthma, and chronic obstructive pulmonary disease. 16 Among primary care outpatients with hypertension … leading causes of activity limitation included arthritis, back/neck pain, heart disease, diabetes, hypertension … physical conditions examined in the NICE guideline included diabetes, cancer, asthma, stroke, arthritis, hypertension
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-chronic-conditions-interventions_research-protocol.pdf
    September 21, 2011 - diabetes, asthma, and chronic obstructive pulmonary disease. 16 Among primary care outpatients with hypertension … leading causes of activity limitation included arthritis, back/neck pain, heart disease, diabetes, hypertension … physical conditions examined in the NICE guideline included diabetes, cancer, asthma, stroke, arthritis, hypertension
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
    November 27, 2012 - One patient was reported to have hypertension in the methotrexate group (1.59 percent) while no cases … One patient was reported to have hypertension in patients who switched from methotrexate to infliximab … We incorporated the following details “One patient (1.59 percent) was reported to have hypertension
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
    January 01, 2023 - infarction, coronary ischemia, coronary revascularization, congestive heart failure (CHF), arrhythmia, hypertension … Other than hypertension and hyperlipidemia, the prevalences of various cardiovascular disease conditions … 556 0.2% Coronary artery anomaly 66 0.0% 89 0.0% Peripheral vascular disease 1225 0.8% 1651 0.6% Hypertension … 0.8% 656.2 1.0% 2926.2 0.5% Arrhythmia 2230.7 2.1% 1151.5 2.2% 1121.2 2.4% 1772.5 2.6% 8976.4 1.7% Hypertension … , congenital heart disorder, coronary artery anomaly, peripheral vascular disease, hyperlipidemia, hypertension
  18. S103 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s103.pdf
    October 01, 2007 - Physicians are frequently confronted with patients who are taking older �-blockers for the treatment of hypertension … October 2007 Inverse Probability-Weighted Estimators © 2007 Lippincott Williams & Wilkins S105 hypertension
  19. Arcia-notes-Teresa (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/arcia-presentation.pdf
    November 11, 2015 - It’s focus is on   hypertension, and  the purpose of this project is really to understand   and … This is where that number comes from," and  some risks of high  blood   pressure. … It is modeled  after the Risks of High  Blood  pressure graphic.
  20. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
    January 01, 2021 - Awareness, knowledge, and attitudes toward screening and treatment of masked hypertension in primary

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: